# Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation

> **NCT00513019** · PHASE2 · COMPLETED · sponsor: **University of Chicago** · enrollment: 35 (actual)

## Conditions studied

- Neurotic Excoriation
- Pathologic Skin Picking
- Psychogenic Excoriation
- Dermatillomania

## Interventions

- **DRUG:** Lamictal (lamotrigine)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00513019
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00513019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00513019, "Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00513019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*